Kineta, Inc.
NASDAQ: KA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Craig W. Philips
- Employees
- 11
- Headquarters
- Seattle, United States
- IPO year
- 2016
- Market cap
- $7.0M
- Website
- https://kinetabio.com
Loading KA…
Loading profile data…Frequently asked questions about KA
What does Kineta, Inc. (KA) do?
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collabor...
Where does KA trade?
Kineta, Inc. (KA) trades on the NASDAQ Capital Market.
What sector is KA in?
Kineta, Inc. (KA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Kineta, Inc.?
Craig W. Philips is the chief executive officer of Kineta, Inc. (KA).
Where is Kineta, Inc. headquartered?
Kineta, Inc. is headquartered in United States.
Does KA pay a dividend?
Kineta, Inc. (KA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KA go public?
Kineta, Inc. (KA) completed its initial public offering in 2016.